These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8445281)

  • 21. [Emergency management of hemophiliac patients with suspected hemorrhage. National Agency of Accreditation and Evaluation in Health (ANAES)].
    Presse Med; 1999 Mar; 28(11):591-5. PubMed ID: 10214384
    [No Abstract]   [Full Text] [Related]  

  • 22. [Virus in hemophilia: current status and future perspectives].
    Aguilar C; Félix Lucía J
    Sangre (Barc); 1996 Apr; 41(2):141-5. PubMed ID: 9045355
    [No Abstract]   [Full Text] [Related]  

  • 23. [Evaluation of the efficiency of the locomotor system in children with hemophilia treated in Olsztyn Province 1981-1986].
    Makowska K; Kołtun W; Lipecki W
    Pediatr Pol; 1988 May; 63(5):291-7. PubMed ID: 3217173
    [No Abstract]   [Full Text] [Related]  

  • 24. Gene transfer as an approach to treating hemophilia.
    High KA
    Semin Thromb Hemost; 2003 Feb; 29(1):107-20. PubMed ID: 12640573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonsurgical management of hemophilic arthropathy.
    Greene WB; McMillan CW
    Instr Course Lect; 1989; 38():367-81. PubMed ID: 2649587
    [No Abstract]   [Full Text] [Related]  

  • 26. [Transmission of hepatitis C by factor concentrates].
    Aguilar C; Lucía JF
    Sangre (Barc); 1996 Apr; 41(2):160-1. PubMed ID: 9045360
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hemophilia and the acquired immune deficiency syndrome (AIDS)].
    Sjamsoedin-Visser EJ; Breederveld C; Sixma JJ
    Ned Tijdschr Geneeskd; 1983 Jun; 127(23):1008-9. PubMed ID: 6877397
    [No Abstract]   [Full Text] [Related]  

  • 28. Disseminated intravascular coagulation after factor IX complex resolved using purified factor IX concentrate.
    Hadley T; Djulbegovic B
    Ann Intern Med; 1991 Oct; 115(8):621-2. PubMed ID: 1892334
    [No Abstract]   [Full Text] [Related]  

  • 29. Development and maintenance of hemophilia care program in Korea.
    Kim KY
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():52-60. PubMed ID: 7886608
    [No Abstract]   [Full Text] [Related]  

  • 30. Bleeding and clotting: new therapies and old issues revisited.
    Lee CA; Aledort LM
    Haemophilia; 2009 Mar; 15(2):592-6. PubMed ID: 19335754
    [No Abstract]   [Full Text] [Related]  

  • 31. Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors.
    Snyder RO; Miao C; Meuse L; Tubb J; Donahue BA; Lin HF; Stafford DW; Patel S; Thompson AR; Nichols T; Read MS; Bellinger DA; Brinkhous KM; Kay MA
    Nat Med; 1999 Jan; 5(1):64-70. PubMed ID: 9883841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viral vector-mediated gene therapy for hemophilia B.
    Eisensmith RC; Woo SL
    Thromb Haemost; 1997 Jul; 78(1):24-30. PubMed ID: 9198122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of purified factor IX concentrate and antifibrinolytic agents for dental extractions in hemophilia B.
    Djulbegovic B; Marasa M; Pesto A; Kushner GM; Hadley T; Joseph G; Goldsmith G
    Am J Hematol; 1996 Feb; 51(2):168-70. PubMed ID: 8579061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor IX deficiency and anaphylaxis.
    Stones DK; McGill N
    S Afr Med J; 2000 Jan; 90(1):50. PubMed ID: 10721392
    [No Abstract]   [Full Text] [Related]  

  • 35. Antibodies to factor IX.
    Warrier I
    Haematologica; 2000 Oct; 85(10 Suppl):31-3; discussion 33-4. PubMed ID: 11187867
    [No Abstract]   [Full Text] [Related]  

  • 36. Gene therapy for haemophilia "A" and "B": efficacy, safety and immune consequences.
    Chuah MK; Vandendriessche T
    Bull Mem Acad R Med Belg; 2007; 162(5-6):357-61. PubMed ID: 18405006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemophilia: What the Oral and Maxillofacial Surgeon Needs to Know.
    Smith JA
    Oral Maxillofac Surg Clin North Am; 2016 Nov; 28(4):481-489. PubMed ID: 27745618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical and clinical gene therapy for haemophilia.
    Chuah MK; Collen D; Vandendriessche T
    Haemophilia; 2004 Oct; 10 Suppl 4():119-25. PubMed ID: 15479384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical animal models for hemophilia gene therapy: predictive value and limitations.
    Rawle FE; Lillicrap D
    Semin Thromb Hemost; 2004 Apr; 30(2):205-13. PubMed ID: 15118932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of severe hand injuries in a patient with hemophilia B].
    Chantsev AV; Raspopova EA
    Vestn Khir Im I I Grek; 2000; 159(5):99-100. PubMed ID: 11188831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.